ALPN and VRTX may merge surge of bullish momentum LONG

AwesomeAvani Updated   
Alpine is a biotech stock that had an earnings report beating estimates two weeks ago. It

is now reaching for all-time highs. That said, it is burning cash just slowing down the burn.

Both revenue and earnings showed remarkable improvement as compared with the previous

quarter. The bullish momentum of price and volume is obvious on the weeky chart with

the print of a massive bullish engulfing candle. Another earnings report is

due in 4 weeks. In the meanwhile, the news catalyst is VRTX and ALPN may be merging.

I will take a risky long trade here with a stop loss at 50 and a profit first target

of 80 and the second at 90.
Trade active:
Gap higher on massive volume. 25% taken off due to risk of a reversal. Fanstastic trade so far including several call options over 100% overnight, One call option
closed.maybe another tomorrow. All is good. Biotech on fire.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.